Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selma Ugurel

Showing results (111-120 of 265) with videos related to

Pageof 27
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 31, 2023
S1-guideline cutaneous and subcutaneous leiomyosarcomaDoris Helbig, Edgar Dippel, Michael Erdmann, et al.
Lancet (London, England)|September 22, 2018
MelanomaDirk Schadendorf, Alexander C J van Akkooi, Carola Berking, et al.
Archives of Dermatology|June 20, 2007
Imatinib as a treatment option for systemic non-Langerhans cell histiocytosesJochen Utikal, Selma Ugurel, Hjalmar Kurzen, et al.
Medical Image Analysis|March 20, 2024
CellViT: Vision Transformers for precise cell segmentation and classificationFabian Hörst, Moritz Rempe, Lukas Heine, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2007
Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapySelma Ugurel, David Schrama, Gunhild Keller, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2019
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case seriesSelma Ugurel, Ivelina Spassova, Jonas Wohlfarth, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanomaSelma Ugurel, Felix Kiecker, Stefan Fröhling, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2018
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patientsMichael Constantin Kirchberger, Selma Ugurel, Johanna Mangana, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2016
Checkpoint inhibitors in chronic kidney failure and an organ transplant recipientSaskia Herz, Thomas Höfer, Matina Papapanagiotou, et al.
Eneurologicalsci|February 19, 2021
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapySaskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, et al.
Pageof 27

Showing results (111-120 of 265) with videos related to

Sort By:
Pageof 27
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 31, 2023
S1-guideline cutaneous and subcutaneous leiomyosarcomaDoris Helbig, Edgar Dippel, Michael Erdmann, et al.
Lancet (London, England)|September 22, 2018
MelanomaDirk Schadendorf, Alexander C J van Akkooi, Carola Berking, et al.
Archives of Dermatology|June 20, 2007
Imatinib as a treatment option for systemic non-Langerhans cell histiocytosesJochen Utikal, Selma Ugurel, Hjalmar Kurzen, et al.
Medical Image Analysis|March 20, 2024
CellViT: Vision Transformers for precise cell segmentation and classificationFabian Hörst, Moritz Rempe, Lukas Heine, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2007
Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapySelma Ugurel, David Schrama, Gunhild Keller, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2019
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case seriesSelma Ugurel, Ivelina Spassova, Jonas Wohlfarth, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanomaSelma Ugurel, Felix Kiecker, Stefan Fröhling, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2018
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patientsMichael Constantin Kirchberger, Selma Ugurel, Johanna Mangana, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2016
Checkpoint inhibitors in chronic kidney failure and an organ transplant recipientSaskia Herz, Thomas Höfer, Matina Papapanagiotou, et al.
Eneurologicalsci|February 19, 2021
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapySaskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, et al.
Pageof 27